.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
UBS
Julphar
Cipla
Federal Trade Commission
Deloitte
Fish and Richardson
Express Scripts
Moodys
Colorcon

Generated: December 16, 2017

DrugPatentWatch Database Preview

VALGANCICLOVIR HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Valganciclovir Hydrochloride patents expire, and when can generic versions of Valganciclovir Hydrochloride launch?

Valganciclovir Hydrochloride is a drug marketed by Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Endo Pharms Inc, and Hetero Labs Ltd V. and is included in five NDAs.

The generic ingredient in VALGANCICLOVIR HYDROCHLORIDE is valganciclovir hydrochloride. There are fifteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the valganciclovir hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl IncVALGANCICLOVIR HYDROCHLORIDEvalganciclovir hydrochlorideFOR SOLUTION;ORAL205220-001Jul 18, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Endo Pharms IncVALGANCICLOVIR HYDROCHLORIDEvalganciclovir hydrochlorideTABLET;ORAL200790-001Nov 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdVALGANCICLOVIR HYDROCHLORIDEvalganciclovir hydrochlorideTABLET;ORAL204750-001Mar 31, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdVALGANCICLOVIR HYDROCHLORIDEvalganciclovir hydrochlorideTABLET;ORAL203511-001Nov 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd VVALGANCICLOVIR HYDROCHLORIDEvalganciclovir hydrochlorideTABLET;ORAL205166-001Mar 18, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
McKinsey
Healthtrust
Baxter
Boehringer Ingelheim
UBS
Argus Health
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot